Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

of management are forward-looking statements. The words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to secure FDA approval for our product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology; the progress or success of our research, development and clinical programs, the initiation and completion of our clinical trials, the timing of the interim analyses and the timing or success of our product candidates, particularly VIAject(TM) and VIAtab(TM); our ability to secure additional patents for VIAject(TM) and our other product candidates; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our Quarterly Report on Form 10-Q for the q
'/>"/>
SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 Increase in R&D ... market in Germany through 2020 ... Research report, " Germany Bioinformatics Market Forecast & Opportunities, ... is projected to register a CAGR of over ... tremendous growth on account of rising government funding and ...
(Date:7/6/2015)... 29, 2015 Research and ... "Pharmaceutical Packaging Market in North America 2015-2019" ... market in North America to ... 2014-2019. International regulations regarding safe drug ... which in turn fuels adoption of sustainable packaging. Various ...
(Date:7/6/2015)... 6, 2015 Cardinal Health today announced the ... (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related ... was owned by Court Square Capital Partners. The $1.115 ... and new debt.  Headquartered in ... had revenues of approximately $450 million in 2014. There ...
Breaking Medicine Technology:Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... WOONSOCKET, R.I., Oct. 18, 2011 A recent ... up germs, they are not doing all they can to ... receiving an annual flu shot as recommended by the Centers ... http://photos.prnewswire.com/prnh/20100816/NE50800LOGO) The CDC recommends that anyone ages 6 ...
... With connectivity enabled by Unlimited Systems Interlink integration ... only helps cancer clinics easily meet many of the ... saves time and money by reducing duplicate data entry, ... claims payment and reduced denials. Clinics can ...
Cached Medicine Technology:CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 2CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 3CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 4Navigating Cancer and Unlimited Systems Partner to Provide Cancer Clinics With IT Interoperability to Attain HITECH Act Incentives 2
(Date:7/6/2015)... Grove, Utah (PRWEB) , ... July 06, 2015 , ... ... Kirk Jowers to its executive management team. Most recently, Jowers held the position as ... for ten years. , After spending a decade building the institute, Jowers states that ...
(Date:7/6/2015)... ... , ... Seedstock today announced Pierre Sleiman, founder and CEO of Go ... Agriculture Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 ... Diego, will explore solutions and methodologies that small farmers and entrepreneurs are developing to ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent care ... urgent care center will serve residents and visitors in the Cutler Bay area, giving ... 22nd South Florida location, the new facility will be the fourth to serve Miami-Dade ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud hosting ... Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading talent ... future call center platform. , Promero will implement and manage the private ...
Breaking Medicine News(10 mins):Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3
... Southern Maine in Portland have revealed that Depleted Uranium (DU) ... government has been denying the possibility. ,Previous research ... found that people exposed to DU dust were at little ... dense, inadequately radioactive metal that is used in armour-piercing shells ...
... Cincinnati Childrens Hospital Medical Center study shows that a ... teens when run by pediatricians in the office ... meeting of the Pediatric Academic Societies in Toronto, shows ... six-month study lost weight, according to Robert Siegel, M.D., ...
... No lives have been lost as yet. But the massive wildfire ... smaller structures. There is no sign of its dying down. ... had to be evacuated for a second time when the fire ... additional 570 people who were ordered out of homes east of ...
... giant Nautilus has been awarded a record order worth over ... . This is the biggest ever order placed with a ... follows a joint venture agreement between Talwalkar Better Value Fitness ... and fitness centers in major retail malls across the country. ...
... migrant in Canada has termed as thrilling and ... him to a compensation of 130, 000 US dollars. ... Insurer ,when they refused to pay him accident coverage after he ... was an insect bite by a mosquito carrying the West Nile ...
... human immune system isn't able to stop such cancers as ... better treatment. ,In a small study, the scientists ... cells in a majority of people with this deadly skin ... which normally activates the immune system. Without the ability to ...
Cached Medicine News:Health News:Low-Carb Diet Effective for Teens Trying to Lose Weight 2Health News:Massive Wildfire Forces Evacuation of Hundreds of Home in Florida 2Health News:Researchers Identify Immune Dysfunction in Melanoma Patients 2Health News:Researchers Identify Immune Dysfunction in Melanoma Patients 3
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
Medicine Products: